APA

Lipner M. B., Peng X. L., Jin C., Xu Y., Gao Y., East M. P., Rashid N. U., Moffitt R. A., Herrera Loeza S. G., Morrison A. B., Golitz B. T., Vaziri C., Graves L. M., Johnson G. L. & Yeh J. J. (20210517). Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. : JCI insight.

Chicago

Lipner Matthew B, Peng Xianlu L, Jin Chong, Xu Yi, Gao Yanzhe, East Michael P, Rashid Naim U, Moffitt Richard A, Herrera Loeza Silvia G, Morrison Ashley B, Golitz Brian T, Vaziri Cyrus, Graves Lee M, Johnson Gary L and Yeh Jen Jen. 20210517. Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. : JCI insight.

Harvard

Lipner M. B., Peng X. L., Jin C., Xu Y., Gao Y., East M. P., Rashid N. U., Moffitt R. A., Herrera Loeza S. G., Morrison A. B., Golitz B. T., Vaziri C., Graves L. M., Johnson G. L. and Yeh J. J. (20210517). Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. : JCI insight.

MLA

Lipner Matthew B, Peng Xianlu L, Jin Chong, Xu Yi, Gao Yanzhe, East Michael P, Rashid Naim U, Moffitt Richard A, Herrera Loeza Silvia G, Morrison Ashley B, Golitz Brian T, Vaziri Cyrus, Graves Lee M, Johnson Gary L and Yeh Jen Jen. Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. : JCI insight. 20210517.